Imigran Recovery

Sumatriptan, the active ingredient in Imigran Recovery, is a Triptan (5‑HT1B/1D receptor agonist) presented as an oral tablet for oral use. It treats acute migraine attacks in adults.

GNH USA supplies Imigran Recovery as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Sumatriptan is a selective 5‑HT1B/1D receptor agonist used in the acute treatment of migraine and related headache disorders. - Migraine attack: provides rapid relief of headache pain and associated symptoms when taken at the onset of an attack. - Migraine with aura: reduces the severity and duration of aura-associated migraine episodes. - Cluster headache: can be used for the acute treatment of episodic cluster headache attacks.

Common Side Effects: - Chest discomfort or tightness: mild, transient sensation often reported after dosing. - Tingling or numbness: usually affecting the face, lips, or extremities. - Nausea or abdominal discomfort: mild gastrointestinal upset. - Dizziness or light‑headedness: may occur shortly after administration. - Fatigue or drowsiness: a feeling of reduced energy.

Serious or Rare Side Effects: - Coronary vasospasm or myocardial ischemia: rare but potentially life‑threatening cardiac events. - Serotonin syndrome: severe reaction when combined with other serotonergic agents. - Severe allergic reaction (anaphylaxis): rapid onset of rash, swelling, or breathing difficulty. - Hypertension or hypertensive crisis: marked increase in blood pressure. - Stroke or transient ischemic attack: extremely rare cerebrovascular events.

Before using Imigran Recovery, consider the following precautions to ensure safe use. - Cardiovascular assessment: evaluate history of coronary artery disease, uncontrolled hypertension, or cerebrovascular disorders. - Concomitant serotonergic drugs: avoid use with SSRIs, SNRIs, MAO inhibitors, or other triptans due to serotonin syndrome risk. - Pregnancy and lactation: discuss potential risks with a healthcare professional; data are limited. - Age considerations: use with caution in elderly patients who may have comorbid conditions. - Storage: Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Sumatriptan may interact with several medication classes; awareness helps prevent adverse events. Major Interactions (Avoid): - MAO inhibitors: combined use can precipitate serotonin syndrome. - Other triptans or ergot alkaloids: increased risk of vasospasm and cardiovascular events. - SSRIs, SNRIs, or other serotonergic agents: heightened serotonin toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise sumatriptan plasma levels. - Certain antihypertensives (e.g., propranolol): can elevate exposure and side‑effect risk.

Moderate Interactions (Monitor Closely): - Antihistamines: may enhance dizziness or sedation. - Oral contraceptives: monitor for increased migraine frequency. - NSAIDs: concurrent use may increase gastrointestinal discomfort. - CYP2D6 inhibitors (e.g., fluoxetine): may modestly increase sumatriptan exposure. - Diuretics: watch for blood pressure fluctuations.